SouthState Corp’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09K Buy
8
+4
+100% +$491 ﹤0.01% 1095
2026
Q1
$472 Hold
4
﹤0.01% 1193
2025
Q4
$656 Hold
4
﹤0.01% 1189
2025
Q3
$535 Sell
4
-1
-20% -$121 ﹤0.01% 1227
2025
Q2
$622 Sell
5
-9
-64% -$1.15K ﹤0.01% 1380
2025
Q1
$1.78K Buy
+14
New +$2.15K ﹤0.01% 1213
2024
Q2
Sell
-377
Closed -$69.3K 747
2024
Q1
$69.3K Buy
+377
New +$71.8K 0.01% 347

Other funds holding RGEN

SouthState Corp's RGEN Position: Q2 2026 in Review

SouthState Corp increased its Repligen (RGEN) stake by 100% in Q2 2026, buying an estimated $491 and bringing the position to 8 shares worth $1.09K. The position accounts for ﹤0.01% of the portfolio, ranked #1095.

SouthState Corp first reported a position in RGEN in Q1 2024 and has held it in 7 quarters since. The position peaked at $69.3K in Q1 2024. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • SouthState Corp held 8 shares of Repligen worth $1.09K as of Q2 2026.
  • SouthState Corp bought 4 Repligen shares in Q2 2026, an estimated $491.
  • Repligen made up ﹤0.01% of SouthState Corp's portfolio in Q2 2026, its #1095 holding.
  • SouthState Corp first reported a position in Repligen in Q1 2024 and has held it in 7 quarters since.
  • SouthState Corp's Repligen position peaked at $69.3K in Q1 2024.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on SouthState Corp's 13F filing for Q2 2026, filed 6 Aug 2026.